353 related articles for article (PubMed ID: 30006244)
21. pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery: in vitro and in vivo evaluation.
Fan B; Xing Y; Zheng Y; Sun C; Liang G
Drug Deliv; 2016; 23(1):238-47. PubMed ID: 24865290
[TBL] [Abstract][Full Text] [Related]
22. Improved synthesis of quaternary ammonium-chitosan conjugates (N+ -Ch) for enhanced intestinal drug permeation.
Zambito Y; Zaino C; Uccello-Barretta G; Balzano F; Di Colo G
Eur J Pharm Sci; 2008 Apr; 33(4-5):343-50. PubMed ID: 18296036
[TBL] [Abstract][Full Text] [Related]
23. Labrasol
Heade J; Maher S; Bleiel SB; Brayden DJ
J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
[TBL] [Abstract][Full Text] [Related]
24. In vivo brain microdialysis to evaluate FITC-dextran encapsulated immunopegylated nanoparticles.
Bommana MM; Kirthivasan B; Squillante E
Drug Deliv; 2012 Aug; 19(6):298-306. PubMed ID: 22928708
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
26. Delivery of natural polyphenols by polymeric nanoparticles improves the resistance of endothelial progenitor cells to oxidative stress.
Felice F; Zambito Y; Belardinelli E; D'Onofrio C; Fabiano A; Balbarini A; Di Stefano R
Eur J Pharm Sci; 2013 Nov; 50(3-4):393-9. PubMed ID: 23988846
[TBL] [Abstract][Full Text] [Related]
27. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
[TBL] [Abstract][Full Text] [Related]
29. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
30. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
31. Development of nanoparticulate drug delivery systems based on thiolated poly(acrylic acid).
Thaurer MH; Deutel B; Schlocker W; Bernkop-Schnürch A
J Microencapsul; 2009 May; 26(3):187-94. PubMed ID: 18946801
[TBL] [Abstract][Full Text] [Related]
32. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder.
Barthelmes J; Perera G; Hombach J; Dünnhaupt S; Bernkop-Schnürch A
Int J Pharm; 2011 Sep; 416(1):339-45. PubMed ID: 21726619
[TBL] [Abstract][Full Text] [Related]
33. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
34. Bioadhesion and oral absorption of enoxaparin nanocomplexes.
Sun W; Mao S; Wang Y; Junyaprasert VB; Zhang T; Na L; Wang J
Int J Pharm; 2010 Feb; 386(1-2):275-81. PubMed ID: 19958824
[TBL] [Abstract][Full Text] [Related]
35. Combination of SEDDS and Preactivated Thiomer Technology: Incorporation of a Preactivated Thiolated Amphiphilic Polymer into Self-Emulsifying Delivery Systems.
Hetényi G; Griesser J; Nardin I; Bernkop-Schnürch A
Pharm Res; 2017 Jun; 34(6):1171-1179. PubMed ID: 28283859
[TBL] [Abstract][Full Text] [Related]
36. Mucoadhesive nanoparticles made of thiolated quaternary chitosan crosslinked with hyaluronan.
Zambito Y; Felice F; Fabiano A; Di Stefano R; Di Colo G
Carbohydr Polym; 2013 Jan; 92(1):33-9. PubMed ID: 23218262
[TBL] [Abstract][Full Text] [Related]
37. Mucus permeating thiomer nanoparticles.
Köllner S; Dünnhaupt S; Waldner C; Hauptstein S; Pereira de Sousa I; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):265-72. PubMed ID: 25603199
[TBL] [Abstract][Full Text] [Related]
38. Permeation enhancement via thiolation: in vitro and ex vivo evaluation of hyaluronic acid-cysteine ethyl ester.
Laffleur F; Psenner J; Suchaoin W
J Pharm Sci; 2015 Jul; 104(7):2153-60. PubMed ID: 25900642
[TBL] [Abstract][Full Text] [Related]
39. Improved nasal bioavailability of FITC-dextran (Mw 4300) from mucoadhesive microspheres in rabbits.
El-Shafy MA; Kellaway IW; Taylor G; Dickinson PA
J Drug Target; 2000; 7(5):355-61. PubMed ID: 10721797
[TBL] [Abstract][Full Text] [Related]
40. About the impact of water movement on the permeation behaviour of nanoparticles in mucus.
Fabiano A; Zambito Y; Bernkop-Schnürch A
Int J Pharm; 2017 Jan; 517(1-2):279-285. PubMed ID: 27979763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
